Connection

AZIZ SHAIBANI to Aged

This is a "connection" page, showing publications AZIZ SHAIBANI has written about Aged.
Connection Strength

0.110
  1. Refractory Chronic Immune-mediated Demyelinating Polyneuropathy. Neurol Clin. 2020 08; 38(3):591-605.
    View in: PubMed
    Score: 0.031
  2. Distal Myopathies: Case Studies. Neurol Clin. 2016 Aug; 34(3):547-64.
    View in: PubMed
    Score: 0.024
  3. Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study. Pain Med. 2012 Feb; 13(2):243-54.
    View in: PubMed
    Score: 0.017
  4. Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT. Neurology. 2021 03 23; 96(12):e1595-e1607.
    View in: PubMed
    Score: 0.008
  5. Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor. Clin Transl Sci. 2021 05; 14(3):1176-1184.
    View in: PubMed
    Score: 0.008
  6. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. Lancet Neurol. 2019 09; 18(9):834-844.
    View in: PubMed
    Score: 0.007
  7. Randomized Trial of Thymectomy in Myasthenia Gravis. N Engl J Med. 2016 08 11; 375(6):511-22.
    View in: PubMed
    Score: 0.006
  8. Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy. J Peripher Nerv Syst. 2015 Dec; 20(4):363-71.
    View in: PubMed
    Score: 0.006
  9. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain. 2007 Feb; 23(2):150-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.